Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$155.97 - $200.09 $701,085 - $899,404
-4,495 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$193.69 - $247.03 $36,413 - $46,441
188 Added 4.36%
4,495 $1.1 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $116,508 - $148,373
-1,041 Reduced 19.47%
4,307 $590,000
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $495,545 - $775,139
5,348 New
5,348 $630,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Peregrine Asset Advisers, Inc. Portfolio

Follow Peregrine Asset Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.